Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ) (1) in ...
Now, an innovative drug development trial will be available in emergency departments of 18 level 1 trauma sites nationwide. It is being launched by UC San Francisco and the Transforming Research and ...